Increased Frequency of ICOS+ CD4 T Cells as a Pharmacodynamic Biomarker for Anti-CTLA-4 Therapy

Authors

Keywords

Journal

Volume 1, Issue 4, Pages 229-234

Publisher

American Association for Cancer Research (AACR)

Online

2013-08-01

DOI

10.1158/2326-6066.cir-13-0020

Discuss science. Find collaborators. Network.

Join a conversation

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started